Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Quarterly Report...NET licensing revenue

Basically nothing for licensing this quarter...


Equity in earnings of affiliated companies
109,739


That's only 109K out of 2,775,000 in revenue for the quarter...77% of revenue went to Operating Expenses ( this number gets higher by every quarter percent -wise)...leaving a net of only 645K In total and out of that we only got ....109K...

Why so low...they made an agreement to pay off TPL expenses for certain "activites related to possible amendments in patent laws"...darn they got all their bases covered and their costs too...so much for a even split of the business...


........

On November 13, 2008, PDS’ management committee resolved to pay TPL 3% of the gross licensing revenue received by PDS for the period June 1, 2008 through May 31, 2009, as reimbursement for certain expenses incurred by TPL in connection with TPL’s activities related to a possible amendment of patent laws in the United States. The aggregate reimbursement under this resolution shall not exceed $1,000,000 for the period June 1, 2008 through May 31, 2009. After May 31, 2009, PDS’ management committee will consider the extension of the reimbursement program, but is not committed at this time to extend the program. During November 2008, PDS paid $571,500 to TPL pursuant to this resolution.

....................................... 11/30/08

Revenues
$ 2,775,000 $ 19,433,000 $ 19,050,000 $ 20,933,000
Operating expenses
2,144,072 9,632,216 4,086,632 13,598,760
Operating income
630,928 9,800,784 14,963,368 7,334,240
Interest income
14,739 47,124 43,378 112,585
Net income
$ 645,667
Share
New Message
Please login to post a reply